Description

This issue of Vital Signs, released on May 14, 2007, provides a strategic overview of competitive dynamics in the cholesterol drug market. Additionally, an emerging company profile is provided for Aegis Therapeutics, a specialty pharmaceutical company specializing in drug delivery technologies. Reimbursement and regulatory news from the FDA is also provided for April 30 - May 4, 2007.